Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)
Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY
This study aims to establish an ambispective cohort platform centered on the pathological axis of sarcopenia-metabolic disorders-aging progression, integrating multimodal data including demographic characteristics, lifestyle factors, clinical phenotypes, laboratory tests, medical imaging, and biospecimens. Namely 'Sarcopenia, Metabolic Diseases, and Integrated Aging Longitudinal Evaluation (SMILE)'.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:
• Adults aged 18 and over
Locations
Other Locations
China
Department of Geriatrics, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China.
RECRUITING
Shanghai
Contact Information
Primary
融 黄, Ph.D
11084@renji.com
+862168383816
Time Frame
Start Date: 2020-12-01
Estimated Completion Date: 2040-12-31
Participants
Target number of participants: 10000
Related Therapeutic Areas
Sponsors
Leads: RenJi Hospital